Wnt/β-catenin aids in regulating the proliferation of hepG2 cells mediated by thy-1

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 5115-5127

  Cheng, B Q ^a   Jiang, Y ^b   Zhu, Q ^a   Lin, W G ^a  

^a FUZHOU SECOND HOSPITAL AFFILIATED TO XIAMEN UNIVERSITY   (China)

^b FUZHOU GENERAL HOSPITAL   (China)

Author keywords

Apoptosis; Aspirin; Proliferation; Thy 1; Wnt catenin

Indexed keywords

BETA CATENIN; CYCLIN D1; THY 1 ANTIGEN; WNT PROTEIN; ACETYLSALICYLIC ACID; CTNNB1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; EXPRESSION VECTOR; GENETIC TRANSFECTION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TRANSGENE; WNT SIGNALING PATHWAY;

ANTIGENS, THY-1; APOPTOSIS; ASPIRIN; BETA CATENIN; CELL PROLIFERATION; CYCLIN D1; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; TRANSGENES; WNT SIGNALING PATHWAY;

EID: 84903976180     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.July.7.4     Document Type: Article

References (28)

1. Abou-Alfa GK (2006). Hepatocellular carcinoma: molecular biology and therapy. Semin. Oncol. 33: S79-S83.
2. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, et al. (2005). Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294: 914-923.
3. Cheng BQ, Jiang Y, Li DL, Fan JJ, et al. (2012). Up-regulation of thy-1 promotes invasion and metastasis of hepatocarcinomas. Asian Pac. J. Cancer Prev. 13: 1349-1353.
4. Chiba T, Kita K, Zheng YW, Yokosuka O, et al. (2006). Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44: 240-251.
5. Cohen PY, Breuer R and Wallach-Dayan SB (2009). Thy1 up-regulates FasL expression in lung myofibroblasts via Src family kinases. Am. J. Respir. Cell Mol. Biol. 40: 231-238.
6. Colombo F, Baldan F, Mazzucchelli S, Martin-Padura I, et al. (2011). Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma. PLoS One 6: e21369.
7. Conrad DM, Furlong SJ, Doucette CD, Boudreau RT, et al. (2009). Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation. Cell Signal. 21: 1298-1307.
8. Dihlmann S, Siermann A and von Knebel DM (2001). The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. Oncogene 20: 645-653.
9. Dihlmann S, Klein S and Doeberitz MM (2003). Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin. Mol. Cancer Ther. 2: 509-516.
10. Fevr T, Robine S, Louvard D and Huelsken J (2007). Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol. Cell. Biol. 27: 7551-7559.
11. Haile RW, Yochim JM, Cortessis VK, Lin J, et al. (2005). A molecular/epidemiologic analysis of expression of cyclooxygenases 1 and 2, use of nonsteroidal antiinflammatory drugs, and risk of colorectal adenoma. Clin. Colorectal. Cancer 4: 390-395.
12. Hawcroft G, D'Amico M, Albanese C, Markham AF, et al. (2002). Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells. Carcinogenesis 23: 107-114.
13. Ho DW, Yang ZF, Yi K, Lam CT, et al. (2012). Gene expression profiling of liver cancer stem cells by RNA-sequencing. PLoS One 7: e37159.
14. Lee TK, Castilho A, Ma S and Ng IO (2009). Liver cancer stem cells: implications for a new therapeutic target. Liver Int. 29: 955-965.
15. Lingala S, Cui YY, Chen X, Ruebner BH, et al. (2010). Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp. Mol. Pathol. 89: 27-35.
16. Lu JW, Chang JG, Yeh KT, Chen RM, et al. (2011). Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis. Acta Histochem. 113: 833-838.
17. Ma S, Chan KW, Hu L, Lee TK, et al. (2007). Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132: 2542-2556.
18. Marquardt JU, Factor VM and Thorgeirsson SS (2010). Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. J. Hepatol. 53: 568-577.
19. Neth P, Ries C, Karow M, Egea V, et al. (2007). The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion. Stem Cell Rev. 3: 18-29.
20. Rege TA and Hagood JS (2006). Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 20: 1045-1054.
21. Suetsugu A, Nagaki M, Aoki H, Motohashi T, et al. (2006). Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem. Biophys. Res. Commun. 351: 820-824.
22. Takigawa Y and Brown AM (2008). Wnt signaling in liver cancer. Curr. Drug Targets 9: 1013-1024.
23. Visvader JE (2011). Cells of origin in cancer. Nature 469: 314-322.
24. Yam JW, Wong CM and Ng IO (2010). Molecular and functional genetics of hepatocellular carcinoma. Front Biosci (Schol. Ed) 2: 117-134.
25. Yang SH, Chen YJ, Tung PY, Lai WL, et al. (2008). Anti-Thy-1 antibody-induced neurite outgrowth in cultured dorsal root ganglionic neurons is mediated by the c-Src-MEK signaling pathway. J. Cell. Biochem. 103: 67-77.
26. Yang ZF, Ho DW, Ng MN, Lau CK, et al. (2008). Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13: 153-166.
27. Yang ZF, Ngai P, Ho DW, Yu WC, et al. (2008). Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 47: 919-928.
28. Zhou BB, Zhang H, Damelin M, Geles KG, et al. (2009). Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat. Rev. Drug Discov. 8: 806-823.